![]() Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | ![]() Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. | ||
Founding Date | Founding Date 1991 | Founding Date 2007 | Founding Date 1994 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Sunnyvale, US HQ | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US | Locations Alameda, US HQ |
Employees | Employees 6551% decrease | Employees 1,017 | Employees 1,14712% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 7.7 b | Valuation ($) 8.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) €720.1m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods $40.4m (FY, 2014) | Cost of goods €93.1m (FY, 2025) | Cost of goods $83.7m (FY, 2025) |
Gross profit | Gross profit $689.3m (FY, 2014) | Gross profit €627.1m (FY, 2025) | Gross profit $2.2b (FY, 2025) |
Net income | Net income $86.1m (FY, 2014) | Net income (€228m) (FY, 2025) | Net income $782.6m (FY, 2025) |

Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View company
Exelixis is an oncology company that develops cancer treatments.
View company